Fingerprint
Dive into the research topics of 'Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically